Gefurulimab
戈鲁利单抗
Report date: 2025/12/24 11:37:37
Base Information
Drug NameGefurulimab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[22]
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesAlexion Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesAlexion Europe SasAlexion Pharmaceuticals IncAstraZeneca global R & D (China) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A